Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTSO Cytosorbents	$1.03 +4.0%	$1.03	$0.71 ▼ $1.61	$64.49M	1.19	145,785 shs	22,379 shs
HYPR Hyperfine	$0.92 -10.7%	$0.72	$0.53 ▼ $1.90	$71.61M	1.01	914,186 shs	574,341 shs
IINN Inspira Technologies OXY B.H.N.	$1.41 -4.1%	$0.83	$0.40 ▼ $1.65	$17.80M	2.24	608,993 shs	696,210 shs
SURG SurgePays	$2.91 -1.0%	$2.96	$1.05 ▼ $3.47	$59.40M	0.46	629,318 shs	47,689 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTSO Cytosorbents	+4.04%	-2.83%	-11.21%	0.00%	-6.36%
HYPR Hyperfine	-10.67%	+19.65%	+31.59%	+32.18%	-23.33%
IINN Inspira Technologies OXY B.H.N.	-4.08%	+17.50%	+88.78%	+140.49%	+12.80%
SURG SurgePays	-1.02%	-7.32%	+3.56%	+16.87%	-5.52%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CTSO Cytosorbents	1.7572 of 5 stars	3.5	1.0	2.9	0.0	0.6
HYPR Hyperfine	1.6719 of 5 stars	2.3	4.0	0.6	2.5	0.6
IINN Inspira Technologies OXY B.H.N.	2.1778 of 5 stars	3.5	3.0	1.9	1.7	0.0
SURG SurgePays	3.0368 of 5 stars	3.5	5.0	1.5	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTSO Cytosorbents	3.00	Buy	$5.50	433.98% Upside
HYPR Hyperfine	2.67	Moderate Buy	$1.06	15.20% Upside
IINN Inspira Technologies OXY B.H.N.	3.00	Buy	$2.00	41.84% Upside
SURG SurgePays	3.00	Buy	$9.00	209.28% Upside

Current Analyst Ratings Breakdown

Latest IINN, CTSO, HYPR, and SURG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/25/2025	CTSO Cytosorbents	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
6/16/2025	SURG SurgePays	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.75 ➝ $9.00
6/3/2025	HYPR Hyperfine	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
6/2/2025	IINN Inspira Technologies OXY B.H.N.	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/2/2025	IINN Inspira Technologies OXY B.H.N.	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$2.00
5/15/2025	CTSO Cytosorbents	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00
5/15/2025	CTSO Cytosorbents	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$1.00 ➝ $1.00
5/15/2025	HYPR Hyperfine	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$1.20 ➝ $1.00
5/14/2025	HYPR Hyperfine	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$1.29 ➝ $0.68
5/2/2025	CTSO Cytosorbents	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00
4/22/2025	SURG SurgePays	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.50 ➝ $8.75

(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTSO Cytosorbents	$35.60M	1.81	N/A	N/A	$0.20 per share	5.15
HYPR Hyperfine	$12.89M	5.56	N/A	N/A	$0.67 per share	1.37
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	$0.34 per share	N/A
SURG SurgePays	$60.88M	0.98	N/A	N/A	$0.76 per share	3.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTSO Cytosorbents	-$20.72M	-$0.28	N/A	N/A	N/A	-41.77%	-105.04%	-29.18%	8/12/2025 (Estimated)
HYPR Hyperfine	-$40.72M	-$0.54	N/A	N/A	N/A	-343.42%	-74.19%	-62.40%	8/14/2025 (Estimated)
IINN Inspira Technologies OXY B.H.N.	-$11.05M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
SURG SurgePays	-$45.73M	-$2.79	N/A	N/A	N/A	-136.37%	-206.01%	-153.67%	8/12/2025 (Estimated)

Latest IINN, CTSO, HYPR, and SURG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	HYPR Hyperfine	-$0.12	N/A	N/A	N/A	N/A	N/A
8/12/2025	Q2 2025	CTSO Cytosorbents	-$0.07	N/A	N/A	N/A	$9.79 million	N/A
8/12/2025	Q2 2025	SURG SurgePays	-$0.31	N/A	N/A	N/A	$16.14 million	N/A
5/14/2025	Q1 2025	CTSO Cytosorbents	-$0.08	-$0.06	+$0.02	-$0.02	$9.01 million	$8.73 million
5/13/2025	Q1 2025	HYPR Hyperfine	-$0.12	-$0.12	N/A	-$0.12	$2.82 million	$2.14 million
5/13/2025	Q1 2025	SURG SurgePays	-$0.40	-$0.38	+$0.02	-$0.38	$9.80 million	$10.58 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTSO Cytosorbents	N/A	N/A	N/A	N/A	N/A
HYPR Hyperfine	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
SURG SurgePays	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTSO Cytosorbents	0.98	2.61	2.30
HYPR Hyperfine	N/A	6.07	5.48
IINN Inspira Technologies OXY B.H.N.	0.09	2.02	1.89
SURG SurgePays	0.24	1.72	1.41

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTSO Cytosorbents	32.87%
HYPR Hyperfine	15.03%
IINN Inspira Technologies OXY B.H.N.	12.72%
SURG SurgePays	6.94%

Insider Ownership

Company	Insider Ownership
CTSO Cytosorbents	7.30%
HYPR Hyperfine	30.98%
IINN Inspira Technologies OXY B.H.N.	29.40%
SURG SurgePays	30.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTSO Cytosorbents	220	62.61 million	58.04 million	Optionable
HYPR Hyperfine	190	77.83 million	53.72 million	Optionable
IINN Inspira Technologies OXY B.H.N.	20	12.62 million	8.91 million	Not Optionable
SURG SurgePays	40	20.41 million	14.19 million	Optionable

IINN, CTSO, HYPR, and SURG Headlines

Recent News About These Companies

SurgePays (NASDAQ:SURG) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

July 18 at 4:35 AM | marketbeat.com

SurgePays (NASDAQ:SURG) Stock Passes Above 200-Day Moving Average - What's Next?

July 10, 2025 | americanbankingnews.com

SurgePays (NASDAQ:SURG) Stock Passes Above 200-Day Moving Average - Should You Sell?

July 10, 2025 | marketbeat.com

SurgePays Launches New PrePaid Service Smartphones Designed For Convenience Stores And Non-Wireless Retail Channels

July 3, 2025 | twice.comT

SurgePays (NASDAQ:SURG) Share Price Passes Above 200 Day Moving Average - Here's What Happened

July 2, 2025 | marketbeat.com

GPOPlus+ Shareholder Update

June 30, 2025 | accessnewswire.comA

SurgePays launches prepaid phone-in-a-box service for convenience stores

June 27, 2025 | investing.com

SurgePays Launches New Prepaid Service, "Phone-in-a-Box," Designed for Convenience Stores and Non-Wireless Retail Channels

June 26, 2025 | prnewswire.com

SurgePays (NASDAQ:SURG) Share Price Crosses Above Two Hundred Day Moving Average - Here's Why

June 24, 2025 | marketbeat.com

SurgePays to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 24-25

June 11, 2025 | prnewswire.com

SurgePays Confirms Directors and Ratifies Accounting Firm

May 20, 2025 | tipranks.com

AT&T (NYSE:T) Partners With Carbyne For APEX Continuity Emergency Solution For PSAPs

May 20, 2025 | finance.yahoo.com

US$8.75 - That's What Analysts Think SurgePays, Inc. (NASDAQ:SURG) Is Worth After These Results

May 17, 2025 | uk.finance.yahoo.com

SurgePays Secures $7M Convertible Note for Expansion

May 16, 2025 | tipranks.com

Why SurgePays, Inc.’s (SURG) Stock Is Down 19.64%

May 15, 2025 | aaii.comA

Q1 2025 Surgepays Inc Earnings Call

May 15, 2025 | uk.finance.yahoo.com

SurgePays, Inc. (SURG) Q1 2025 Earnings Call Transcript

May 13, 2025 | seekingalpha.com

SurgePays, Inc. (SURG) Reports Q1 Loss, Tops Revenue Estimates

May 13, 2025 | zacks.com

SurgePays Reports First Quarter 2025 Financial Results

May 13, 2025 | prnewswire.com

SurgePays Announces $7 Million Debt Financing to Accelerate Growth

May 13, 2025 | prnewswire.com

SurgePays to Host First Quarter 2025 Financial Results Conference Call on Tuesday, May 13th

May 6, 2025 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
More Than a Monetary Metal: Silver's Case for Outperformance
By Jeffrey Neal Johnson | June 22, 2025
View More Than a Monetary Metal: Silver's Case for Outperformance
Why Freeport-McMoRan Is The Copper King in a Tight Market
By Jeffrey Neal Johnson | July 7, 2025
View Why Freeport-McMoRan Is The Copper King in a Tight Market
RTX Corporation Stock: $93B Defense Backlog Fuels Growth
By Jeffrey Neal Johnson | July 1, 2025
View RTX Corporation Stock: $93B Defense Backlog Fuels Growth

IINN, CTSO, HYPR, and SURG Company Descriptions

Cytosorbents NASDAQ:CTSO

$1.03 +0.04 (+4.04%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$1.02 -0.01 (-0.49%)

As of 07/18/2025 04:08 PM Eastern

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Hyperfine NASDAQ:HYPR

$0.92 -0.11 (-10.67%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$0.89 -0.03 (-3.05%)

As of 07/18/2025 07:41 PM Eastern

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.41 -0.06 (-4.08%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$1.40 0.00 (-0.35%)

As of 07/18/2025 07:56 PM Eastern

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

SurgePays NASDAQ:SURG

$2.91 -0.03 (-1.02%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$2.92 +0.00 (+0.17%)

As of 07/18/2025 07:42 PM Eastern

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time